Features Screener Stocks Charts
Sign In Sign Up

Fresenius Kabi Oncology Ltd. Income Statement

NSE:FKONCO | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year FKONCO income statement snapshot

Hover the chart icon for YoY change.

FY 2012 - FY 2013
Item Chart 2012 2013
Revenue 5.27B 5.96B
Cost of Revenue -2.17B -1.65B
Gross Profit 3.09B 4.31B
Sales, General & Admin -2.43B -2.88B
Operating Income 419.71M 1.17B
Profit Before Tax 716.96M 1.15B
Net Income 509.51M 805.89M
Diluted Shares 158.23M 158.23M
Diluted EPS 3.22 5.09

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2013